HCC tissue samples; paracancerous tissues; plasma samples; serum samples
THLE-2; Huh-7; Hep 3B2.1-7
-
proliferation (inhibits); migration (inhibits); invasion (inhibits); drug resistance (inhibits); other pathway/process (promotes)
RT-qPCR; Microarray; RNase R Treatment; Actinomycin D / DRB Stability Assay; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Western Blot; Luciferase Reporter Assay; ChIP / ChIP-seq; RIP (RNA Immunoprecipitation); ROC Analysis; Bioinformatics Analysis
Serum hsa_circ_0072309 may serve as a noninvasive diagnostic marker for HCC; low hsa_circ_0072309 expression is associated with larger tumor size, lymph node metastasis/vascular invasion, satellite nodules, and elevated alpha-fetoprotein levels.
hsa_circ_0072309 is downregulated in HCC tissues, serum samples, and HCC cell lines, and serum expression shows diagnostic potential. Functionally, it suppresses HCC cell proliferation, migration, invasion, and sorafenib resistance. Mechanistically, hsa_circ_0072309 binds p300 and promotes H3K27ac enrichment at the LIFR enhancer to activate LIFR transcription, forming a positive feedback regulatory loop with its host gene LIFR.
0.8625
hsa_circ_0072309 Inhibits Oncogenesis in Hepatocellular Carcinoma by Epigenetic Activation of its Host Gene.
combined biological and clinical study